Ethical implications of biologic dose escalation in pediatric hidradenitis suppurativa

Authors

• Rahib K. Islam, LSU Health Sciences Center – New OrleansFollow
• Lacey M. Falgout, Tulane University School of Medicine, New Orleans, LA
• Nicholas Culotta, LSU Health Sciences Center – New OrleansFollow
• Christopher J. Haas, LSU Health Sciences Center – New OrleansFollow

Document Type

Letter to the Editor

Publication Date

8-19-2026

Publication Title

Journal of the American Academy of Dermatology

First Page

1

Last Page

2

PubMed ID

42617695

Rights

© 2026 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.

Recommended Citation

Islam, Rahib K.; Falgout, Lacey M.; Culotta, Nicholas; and Haas, Christopher J., "Ethical implications of biologic dose escalation in pediatric hidradenitis suppurativa" (2026). School of Medicine Faculty Publications. 5243.
https://digitalscholar.lsuhsc.edu/som_facpubs/5243
10.1016/j.jaad.2026.08.053